Exhibit 99.1
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad
- 500 034, Telangana, CIN : L85195TG1984PLC004507
Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com |
June 12, 2023
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
Dear Sirs,
Sub: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings
This is to inform you that the Company’s management will be participating in the following investor conference and group / institutional investor meetings:
Date | Organized by | Meeting details | Location | Timing |
13-Jun-23 | Goldman Sachs | 44th Annual Global Healthcare Conference |
California, US |
08:40 to 17:15 hrs PDT (from 9:10 pm IST) |
15-Jun-23 | BofA Securities | Investor group meeting | Virtual | 16:00 to 17:00 hrs IST |
19-Jun-23 | Kotak Securities | Investor group meeting | Hyderabad | 10:00 to 11:00 hrs IST 14:00 to 17:00 hrs IST |
20-Jun-23 | JM Financial Institutional Securities | Investor group meeting | Hyderabad | 10:00 to 11:30 hrs IST |
Please note that the schedules of the aforesaid meetings are subject to change due to any exigencies on the part of Investors / Company.
This is for your information.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
/s/ K Randhir Singh | |
K Randhir Singh |
Company Secretary, Compliance Officer and Head CSR
CC:- | New York Stock Exchange Inc.(Stock Code :RDY) |
NSE IFSC Ltd